Press Release – New York, NY – March 8, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Citius in its acquisition of LM Biosciences, Inc. (“LMB”). LMB is a late-stage specialty pharmaceutical company focused on the development and commercialization of critical care products with a concentration of anti-infective drugs.
The acquisition was an all stock transaction and included a $3 million investment by Citius’ Chairman of the Board. The Sichenzia Ross Friedman Ference LLP was led by Partners Arthur Marcus, Gregory Sichenzia and associate Nazia Khan.
About Sichenzia Ross Friedman Ference LLP
Sichenzia Ross Friedman Ference LLP is a securities and corporate law firm based in New York City that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, mergers and acquisitions, alternative publication offerings, preparation of SEC filings and listing to major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex.
